Combination of transarterial chemoembolization and sorafenib improves outcomes of unresectable hepatocellular carcinoma: an updated systematic review and meta-analysis-Reference-Cited by-同舟云学术

Combination of transarterial chemoembolization and sorafenib improves outcomes of unresectable hepatocellular carcinoma: an updated systematic review and meta-analysis

Published:2018-09-29 Issue:12 Volume:48 Page:1058-1069
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Jin Piao-Piao¹^ORCID,Shao Shi-Yi²,Wu Wang-Teng²,Zhao Xin-Yu²,Huang Bing-Feng²,Fu Qi-Han³,Que Ri-Sheng²,Hu Qi-Da²

Affiliation:

1. Department of Gastroenterology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

2. Department of Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

3. Department of Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Funder

National Natural Science Foundation of China

Zhejiang Provincial Natural Science Foundation

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/48/12/1058/26751318/hyy138.pdf

Reference43 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology,2012

3. EASL clinical practice guidelines: management of hepatocellular carcinoma;European Association for the Study of the Liver;J Hepatol,2018

4. Hepatocellular carcinoma;El-Serag;N Engl J Med,2011

5. Hepatocellular carcinoma;Forner;Lancet,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bland Embolization and Transarterial Chemoembolization in Hepatocarcinoma;Digestive Disease Interventions;2023-10-04

2. Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic Reviews;Journal of Hepatocellular Carcinoma;2023-10

3. Fibrosis and Immunotherapy in Hepatocellular Carcinoma;Interdisciplinary Cancer Research;2023

4. Transarterial Chemoembolization Combined With Tyrosine Kinase Inhibitors for Intermediate‐Stage Hepatocellular Carcinoma, What Else Can We Do?;Frontiers in Oncology;2022-03-29

5. Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis;Translational Oncology;2021-12